stem cell therapies (Duke-NUS/Lund University/Novo Nordisk)

N/A

Report date: 2025/01/26 18:07:11

Base Information

Drug Namestem cell therapies (Duke-NUS/Lund University/Novo Nordisk)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart FailureVision DisordersParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeSwedenDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDuke-Nus Medical School
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/SDuke-Nus Medical SchoolLund University
Inactive CompaniesN/A
Active IndicationsHeart FailureVision DisordersParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A